http://rdf.ncbi.nlm.nih.gov/pubchem/patent/GB-878177-A

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_73ee0bacab5a7576a6a3244747f6ea99
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07C337-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-15
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/B01J31-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07C337-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-15
filingDate 1959-06-17-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_ef9d3962dbc6e4a15a423d635947786c
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_3c3791c2c0e7eaee5229e6172a330806
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_5a0d3a25b83ccc5e7081ab5a77124739
publicationDate 1961-09-27-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber GB-878177-A
titleOfInvention Thiocarbamoylhydrazines
abstract The invention comprises hydrazines of the general formula R1NHCSNHNHCSNR2R3 wherein of the symbols R1 R2 and R3, one stands for an alkyl radical of not more than 4 carbon atoms or for an alkenyl radical and, of the remaining two symbols, one stands for hydrogen or for an alkyl radical of not more than 4 carbon atoms, an alkenyl radical, an aralkyl radical optionally substituted by halogen, methyl or methoxy radicals, a cycloalkyl radical, an alkoxyalkyl radical or an alkylthioalkyl radical and the other stands for an alkyl radical of not more than 4 carbon atoms, an alkenyl radical, an aralkyl radical optionally substituted by halogen, methyl or methoxy radicals, a cycloalkyl radical, an alkoxyalkyl radical or an alkylthioalkyl radical or wherein R1 stands for an alkyl or alkenyl radical, R2 stands for hydrogen and R3 stands for a carbethoxy radical, provided that when R2 stands for hydrogen, R1 and R3 do not both stand for the methyl, ethyl or allyl radicals and, when R1 stands for the methyl radical and R2 for hydrogen, R3 does not stand for the allyl radical and the preparation thereof by p reacting an isothiocyanate of the formula R1NCS (or the corresponding dithiocarbamate derivative R1NHCSSR5, where R5 stands for a methyl or ethyl radical, providing R1NCS under the conditions of the reaction) with a semicarbazide of the formula H2NNHCSNR2R3 or (wherein R1 and R2 stands for the same radical and R3 stands for hydrogen) by reacting an isothiocyanate of the formula R4NCS, wherein R4 stands for an alkyl radical of not more than 4 carbon atoms or for an alkenyl radical, and hydrazine. a -Methylallylisothiocyanate is prepared by reacting g -methylallyl bromide with ammonium thiocyanate. 4 : 4-Di-n-propylthiosemicarbazide is prepared from carbon disulphide di-n-propylamine and sodium chloroacetate which are reacted to yield di-n-propylthiocarbamylthioglycollic acid and reacting this with hydrazine. The Provisional Specification in addition relates to thiocarbamoylhydrazines of the above formula wherein R1 R2 and R3 are hydrocarbon radicals optionally substituted e.g. by halogen, alkoxy or nitro groups.ALSO:Animal feedstuffs and premixes contain one or more this carbamoylhydrozines of the general formula R, NHCSNHNHCSNR2R3 wherein of R1, R2 and R3 one represents an alkyl group containing up to 4 carbon atoms or an alkenyl group and of the other two one represents a hydrogen atom, an alkyl group containing up to 4 carbon atoms, an alkenyl group, an aralkyl group (optionally substituted by halogen atoms, methyl or methoxy groups) a cycloalkyl, an alkythioalkyl or an alkoxyalkyl group and the other represents an alkyl group containing up to 4 carbon atoms, an alkenyl group, an aralkyl group (optionally substituted by halogen atoms, methyl or methoxy groups), a cycloalkyl, an alkoxyalkyl or an alkylthioalkyl group or or when R1 is an alkyl or alkenyl, and R2 is hydrogen R3 is a carbethoxy radical. Premixes preferably contain 0.1-25% and feedstuffs 0.001-1% by weight of the active ingredient.ALSO:Pharmaceutical and veterinary compositions comprise at least one hydrazine derivative of the formula R1NHCSNHNHCSNR2R3 (wherein of the symbols R1 R2 R3, one stands for an alkyl radical of not more than 4 carbon atoms or for an alkenyl radical and of the remaining two symbols, one stands for hydrogen or for an alkyl radical of not more than 4 carbon atoms, an alkenyl radical, an aralkyl radical optionally substituted by halogen atoms, methyl or methoxy radicals, a cycloalkyl, an alkoxyalkyl or an alkylthioalkyl radical and the other stands for an alkyl radical of not more than 4 carbon atoms, an alkenyl radical, an aralkyl radical optionally substituted by halogen atoms, methyl or methoxy radicals, a cycloalkyl, alkoxyalkyl, or alkylthioalkyl radical or wherein R1 stands for an alkyl or alkenyl radical R2 stands for hydrogen and R3 stands for a carbethoxy radical, provided that when R2 stands for hydrogen, R1 and R3 do not both stand for the methyl, ethyl or allyl radical and when R1 stands for the methyl radical and R2 for hydrogen, R3 does not stand for the allyl radical) in admixture with non-toxic pharmaceutically acceptable inert diluents or carriers. The compositions may be in the form of tablets, capsules, solutions or suspensions in aqueous or in non-toxic organic solvent media, dispersible powders suitable for the preparation of liquid suspensions for oral or parenteral use. Examples are given of the preparation of tablets and suspensions in water.
priorityDate 1959-06-17-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID410444215
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID452732198
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID457582482
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID456171974
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID408486386
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID8252
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID962
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID161973038
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID425193155
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458393705
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID454306211
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID297
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID9321
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419512635
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458393636
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5196
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419562437
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458393787
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID411317346
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID783
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID15666
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458427722
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID2723789
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID420315540
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458392451
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6324
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419559527
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID9322
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID23665759
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419527520

Total number of triples: 46.